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Ectopic Pregnancy 
Ectopic pregnancy remains a diagnostic and management challenge for nurse practition- 
ers. The incidence and physiology of ectopic pregnancy, the current research on risk 
factors, detection methods, and management techniques, and counseling strategies are 
reviewed in this article. In addition, a protocol for nurse practitioners to improve the 
management and possibly lessen the serious impact of this challenging complication of 
pregnancy will be discussed. 
Ectopic pregnancy has serious consequences for child- 
bearing women. An oocyte that implants at a site other 
than the endometrium is strongly associated with infer- 
tility and ectopic pregnancy recurrence. It also ac- 
counts for 12% of maternal deaths. The perinatal 
mortality when this occurs is virtually 100% (Kuczynski, 
1986). 
Ectopic pregnancy remains a diagnostic and manage- 
ment challenge for nurse practitioners (NPs). In this 
article the incidence and physiology of ectopic preg- 
nancy will be discussed; the current research on risk 
factors, detection methods, and management tech- 
niques will be reviewed; and counseling strategies will 
be outlined. Finally, development of an NP protocol 
designed to improve the management and possibly 
lessen the serious impact of this challenging complica- 
tion of pregnancy will be discussed. 
INCIDENCE 
The number of ectopic pregnancies continues to 
increase in the United States. Approximately 88,000 
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women in the United States had ectopic pregnancies in 
1987 (Nederlof, Lawson, Saftlas, Atrash, & Finch, 1990). 
Currently, the incidence is approximately 16.8 per 
1,000 reported pregnancies (reported live births, spon- 
taneous or legal abortions, and ectopic pregnancies). 
Ectopic pregnancy surveillance statistics demonstrated 
a steady increase from 17,800 cases in 1970 to 88,000 
cases in 1987 (Nederlof et al., 1990). On a more 
optimistic note, mortality rates have been decreasing 
from the 1970s to the 1980s to 0.5 deaths per 1,000 
cases. Although fewer women are dying, there is still 
room for improvement in the identification of ectopic 
pregnancy in women of childbearing age. 
PATHOPHYSIOLOGY 
Ninety-six percent of ectopic pregnancies occur in 
the distal two thirds of the fallopian tube, 2% are 
interstitial, and 2% are cervical, abdominal, or ovarian. 
The fallopian tube has a total length of 10 to 12 cm 
and is divided into four parts: interstitial, isthmic, 
ampullary, and fimbrial. It is composed of an outer 
serosal layer, a muscular layer, and an inner epithelial 
layer. The tube contains three types of cells (secretory, 
ciliated, and peg) which are influenced by the fluctua- 
tion of estrogen and progesterone levels throughout 
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TABLE 1. 
RESEARCH ON FACTORS ASSOCIATED WITH INCREASED RISK OF ECTOPIC 
~ 
Factor % or Rate Researcher Sample 
Age 
White, age 35-44 




Prior ectopic pregnancy 
Tuba1 surgery 
Black and other minorities 










Unintended pregnancy in a 
progestin IUD user 
Unintended pregnancy in a 
copper IUD user 
Sterilization failure 
3 times more likely than women 
4 times more likely than women 
age 15-24 
age 15-24 
1.4 times that of white women 
2.4-7.9 relative risk 
15%-22% recurrence 
2%-7% 
2.7% of all conceptions were 
ectopic, 3.98 adjusted odds 
ration 
5% ectopic occurrence 
5.6% (24 of 428 pregnancies) 
8.6% (48 of 556 pregnancies) 
Ectopic risk is elevated 2- 
4-5 fold increase in ectoDics 
5 times 
4 times more likely to have had 
Same rate as nonuser of 
an ectopic 
contraception 
1 17 ectopics per 1,000 
37 ectopics per 1,000 




CDC data Nederlof et al., 1990 
Nederlof et al., 1990 CDC data 
Nederlof et al., 1990 
Cates & Wasserheit, 1991 
Joesoef et al., 1991 
Soules et al. as reported in Doyle 
Gemzell et al., 1982 
Fernandez et al., 1991 
et al., 1991 
Data from the 1990 IVF and ET 
registry 
Dor et al., 1991 
Dubuisson et al., 1991 
Reported in Stabile & 
Grudzinkas, 1990 
Reported in Stabile & 
Grudzinkas, 1990 
Fedele et al. as reported in 
Doyle et al., 1991 






Several studies from 1985-1 990 
Historical cohort of 2,501 
women 
Several studies 
289 anovulatory women 
Case controlled study with 
16,405 retrieval cycles 
2,624 retrieval cycles 
3,103 retrieval cycles 
279 women 
161 women with spontaneous 
Retrospective case controlled 
abortions 
study, 615 women with prior 
ectopic and 3,453 matched 
controls 
Review of 290 cases of ectopic 
pregnancy from 1981-1987 
Note. CDC = Centers for Disease Control and Prevention, IVF= in vitro fertilization, ET= embryo transfer, DES = diethylstilbestrol, 
IUD= intrauterine device. 
the menstrual cycle (Russell, 1987). Appropriate secre- 
tion of tubal fluid and synchronized cilia movement 
tacilitate the transport of the fertilized egg to the 
uterus. The fallopian tube, when functioning normally, 
captures the oocyte and transports it to the uterus. Any 
number of factors can disrupt this process. 
In approximately 40% of cases no underlying pathol- 
ogy is found. Damage to the tubal mucosa from various 
sources probably accounts for about half of all ectopic 
pregnancies (Doyle, DeCherney, & Diamond, 1991). 
Other possible mechanisms include immature or post- 
mature eggs which implant at an inappropriate time. 
Additionally, altered estrogen and progesterone levels 
may cause tubal implantation as a result of immobilized 
cilia or smooth muscle. 
RISK FACTORS 
Many risk factors have been associated with the 
occurrence of ectopic pregnancy. Some of these factors 
have been well researched and documented; among 
others, the association is less clear. The research on 
factors associated with increased risk of ectopic preg- 
nancy is presented in Table 1. However, it should be 
emphasized again that in 41.9% of patients no risk 
factors can be identified (Stock, 1988). 
The most frequently examined factor is pelvic inflam- 
matory disease (PID) or salpingitis. Salpingitis, a com- 
mon cause of deciliation, tubal adhesions, and fimbrial 
destruction is usually a result of a sexually transmitted 
infection from either gonorrhea, chlamydia, or mixed 
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aerobe-anaerobe organisms. The tubal damage from 
salpingitis is irreversible; if it is serious enough to cause 
an initial ectopic pregnancy the same intraluminal 
dysfunction remains to cause recurrent ectopic preg- 
nancies. Findings by Cummings, Honore, Scott, and 
Williams (1988) suggest that microscopic tubal damage 
may be important in the genesis of ectopic pregnancy 
even when the tubes have appeared as normal via 
hysterosalpingogram. Although PID represents the most 
clear-cut risk factor for ectopic pregnancy little has 
been done to eliminate it. More aggressive efforts at 
prevention, diagnosis, and prompt treatment are 
needed. NPs need to screen for evidence of PID at 
yearly gynecological examinations because early detec- 
tion and treatment can prevent extensive tubal damage 
(Catlin & Wetzel, 1991). Educating patients about 
prevention of this risk factor and other sexually trans- 
mitted diseases by use of condoms should be a routine 
part of management. 
DETECTION METHODS 
A high index of suspicion should be maintained 
when assessing a patient with a possible ectopic preg- 
nancy. While ectopic pregnancy is associated with all of 
the risk factors listed in Table 1, none of them consis- 
tently lead to the diagnosis. A ruptured ectopic preg- 
nancy is a true life-threatening emergency when the 
patient is unstable, requiring rapid detection and im- 
mediate surgical treatment. Stable patients with un- 
ruptured ectopic pregnancies can be managed in con- 
sultation with a physician. Detection methods, including 
clinical history and examination, biochemical tests, 
ultrasound, endometrial curettage, and laparoscopy, 
are needed to formulate a diagnosis. A review of the 
current research in this area follows. 
CLINICAL HISTORY AND EXAMINATION 
The classic clinical picture of ectopic pregnancy is a 
triad of symptoms: abdominal pain, missed menses, and 
vaginal bleeding. These symptoms also occur in other 
conditions, such as PID, ruptured corpus luteum, 
dysfunctional uterine bleeding, threatened abortion, 
pelvic mass, appendicitis, ureteral colic, gestational 
trophoblastic neoplasia, endometriosis, and intra- 
uterine pregnancy with inaccurate dates. 
Studies show that abdominal pain occurs in 95% to 
100% of patients. The character of the pain has been 
described as cramping, dull, achy, and sharp. The 
severity has been rated as mild, moderate, and severe. 
The pain can be located in any area of the abdomen 
and may be unilateral or bilateral. Missed menses have 






Nausea and vomiting 
Dizziness 
Faintness and syncope 
Breast tenderness 
Urinary tract symptoms 
Shoulder pain 
Diarrhea 
Passage of tissue 
patients experiencing amenorrhea of 6 to 9 weeks 
duration. Many patients become symptomatic 5 to 6 
weeks into the pregnancy depending on the site of 
implantation and fallopian tube accommodation. 
However, these data cannot be relied upon consistently 
because one third of patients will not know the date of 
their last menstrual cycle (Stabile & Grudzinkas, 1990). 
Vaginal bleeding has been reported in 50% to 90% of 
affected populations with varying degrees of severity. 
Clinical symptoms are listed in order of frequency of 
occurrence in Table 2. 
Findings of clinical examinations often vary. A 
common finding is abdominal tenderness; rebound 
tenderness is less frequent. A palpable mass is present 
in approximately one half of patients. Adnexal 
tenderness is present in 98% of patients and pain with 
manipulation of the cervix in 97% (Alsuleiman & 
Grimes, 1982). Blood pressure and pulse vary 
considerably and correlate with amount of blood loss. 
Most patients are afebrile, thus aiding in the differential 
diagnosis of PID. Many studies report a normal-sized 
uterus (Stabile 8c Grudzinkas, 1990). An enlarged 
uterus is described in 25% of cases. Because of the 
extreme variability in the clinical history and 
examination findings, additional diagnostic techniques 
must be used to make accurate diagnoses. 
BIOCHEMICAL TESTS 
The diagnosis of ectopic pregnancy in a clinically 
unstable patient is not a diagnostic dilemma. The 
pregnant patient who is experiencing acute abdominal 
symptoms, vaginal bleeding, and shock is in a life- 
threatening situation with a mortality rate of 0.5 per 
1,000 cases. These patients are immediately sent for 
laparoscopy or laparotomy where the diagnosis is made 
accurately and surgical intervention undertaken. The 
difficult diagnosis of ectopic pregnancy occurs when a 
stable patient early in pregnancy or not yet known to be 
pregnant presents with abdominal pain. 
A stable patient with a human chorionic gonadotropin 
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(HCG) level of <2,000 mIU/mL (which is below the level 
needed to reliably visualize a gestational sac via transvagi- 
nal ultrasound) will benefit from serial HCGs performed 
every 2 days. Approximately 75% of patients with ectopic 
pregnancy will present with this situation. Serial HCG 
testing was developed from the work of Kadar, Caldwell, 
and Romero (1981) who examined HCG doubling times. 
In a normal early intrauterine pregnancy with an HCG 
level of <2,000 mIU/mL, the level doubles every 1.98 
days. In ectopic pregnancy, there is a <66% increase in 
the value in 2 days. 
If the patient is stable, the level can be followed every 
2 days until (a) it is >2,000 mIU/mL where transvaginal 
ultrasound is reliable for detection of intrauterine 
pregnancy; (b) the level falls off or fails to rise, 
indicating probable spontaneous abortion or resolution 
of the ectopic; or (c) the value is rising, but abnormally, 
so that the likelihood of ectopic or spontaneous abor- 
tion still exists. 
In a study conducted by Daus, Mundy, Graves, and 
Slade (1989) of 357 patients with possible ectopic preg- 
nancy there was a significant difference in the HCG levels 
between patients with intrauterine pregnancy and those 
with ectopic and abnormal intrauterine pregnancy. There 
was no significant difference found in HCG levels be- 
tween the ectopic group and the abnormal pregnancy 
group making distinguishing between the two difficult. 
Kadar and Romero (1988) found in their study of 108 
women with possible ectopic pregnancy or spontaneous 
abortion that the HCG levels fell more slowly in women 
with ectopic pregnancy than with spontaneous abortion. 
When the half-life of HCG was C1.4 days, only 7.6% of 
women had ectopic pregnancy; when the half-life was >7 
days, 86% ofwomen had ectopics. Kadar and Romero felt 
that women with rapidly falling levels could be managed 
expectantly. 
When screening patients with possible ectopic preg- 
nancy in an office setting, a pregnancy test sensitive to 
30 mKJ/mL will effectively detect 99% of ectopics 
(Romero et al., 1985). A negative test of this sensitivity 
will virtually exclude the diagnosis of ectopic preg- 
nancy, although rare cases of ectopic with levels of 10 
mIU/mL have been reported. It is important to know 
which test is being performed and at what sensitivity 
level to manage patients with possible ectopic preg- 
nancy in the office setting. 
Other tests performed in the office setting with stable 
patients may include complete blood count with differ- 
ential, blood type and Rh factor, urinalysis for micro- 
scopic evaluation and culture, and cervical cultures for 
gonorrhea and chlamydia. 
ULTRASOUND 
Transvaginal ultrasound can reveal the presence of 
an intrauterine pregnancy 7 days earlier than 
abdominal methods. A gestational sac within the uterus 
can be visualized consistently at levels of 22,000 mIU/ 
mL (Cartwright, 1991), effectively lowering the 
diagnostic gap. Transvaginal ultrasound is also superior 
in identifying other signs of ectopic pregnancy such as 
adnexal mass, extrauterine pregnancy, and free 
peritoneal fluid. Rarely (1 in 30,000) a combination of 
intrauterine and ectopic pregnancy occurs. This 
incidence has been reported as even higher by Stabile 
and Grudzinkas (1990) when in vitro fertilization and 
embryo transfer are used ( 1  in 110). Although this 
situation remains a difficult diagnosis, the use of 
transvaginal ultrasound to detect both the intrauterine 
and ectopic pregnancy is helpful. 
In a study by Thorsen et al. (1990), 193 women with 
suspected ectopic pregnancy were evaluated by 
transvaginal and abdominal ultrasound and HCG 
levels. Transvaginal ultrasound detected 38% of the 
patients with surgically proven ectopic pregnancies; 
abdominal ultrasound detected 22%. All 83 
intrauterine pregnancies were identified with the 
transvaginal approach, whereas only 34 were identified 
with abdominal ultrasound. The authors concluded 
that transvaginal ultrasound was superior to abdominal 
ultrasound in evaluating suspected ectopic pregnancy. 
Bocciolone, Vercellini, Rognoni, Dorta, and Fedele 
(1991) evaluated 116 stable women admitted for 
possible ectopic pregnancies with subacute pelvic pain 
via urine pregnancy test (sensitive to 20 mIU/mL) and 
transvaginal ultrasound. They found the combination 
of urine testing and transvaginal ultrasound to have a 
99% sensitivity and 80% specificity, with positive and 
negative predictive values at 97% and 92%, respectively. 
They concluded that this was a simple, rapid, easily 
available, and accurate method of diagnosing ectopic 
pregnancy in patients with subacute pelvic pain. From 
this information it can be concluded that if available, 
transvaginal ultrasound should be performed in all 
patients suspected of having ectopic pregnancy. 
While transvaginal ultrasound is preferred, there may 
be rural settings where it is not available and abdominal 
ultrasound must be used. The role of abdominal 
ultrasound is to exclude the diagnosis of ectopic 
pregnancy by demonstration of an intrauterine sac, 
assuming ectopic and intrauterine pregnancies rarely 
occur together. Because the ectopic pregnancy and 
other signs of ectopic pregnancy are usually not visible 
with abdominal ultrasound, a pregnancy of 4 weeks 
gestation or 6 weeks from last menstrual period with 
HCG levels of >6,000 mIU/mL is usually visible via this 
approach. Absence of a gestational sac raises the 
suspicion of ectopic pregnancy. 
The date of last menses is unknown in one third of 
252 JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS 
patients (Stabile & Grudzinkas, 1990), and irregular 
bleeding may confuse the date of last menses as well, 
requiring correlation of the presence of a gestational 
sac with HCG levels. Patients with an HCG level of 
*6,000 mIU/mL with an empty uterus on abdominal 
ultrasound should be considered ectopic until proven 
otherwise. 
CULDOCENTESIS 
In culdocentesis the fluid from the transvaginal 
aspiration of the posterior cul-de-sac of Douglas is 
examined. A positive tap is 0.5 cc of nonclotted blood, 
a negative tap is 0.5 cc of serosanguinous fluid, and no 
fluid is considered nondiagnostic. A positive test is 
present in 70% to 90% of patients with ectopic 
pregnancy, but many other conditions where blood 
may pool in the cul-de-sac can cause a false positive such 
as a hemorrhagic corpus luteum cyst, incomplete 
abortion, retrograde menstruation, or endometriosis 
(Cartwright, 1991). Negative taps are obtained from 
10% to 14% of patients with ectopics when there is an 
intact unruptured ectopic or when blood loss is slight 
(Cartwright, 1991; Stabile & Grudzinkas, 1990). 
Culdocentesis cannot be performed in patients with a 
retroverted uterus or mass in the cul-de-sac. The 
procedure is painful and some prefer not to perform it 
in stable patients. In an unstable patient it can provide 
decisive information and often is performed prior to 
surgical intervention. Controversy over the value of 
culdocentesis exists now that transvaginal ultrasound 
has been proven to be an adequate diagnostic proce- 
dure. 
ENDOMETRIAL CURETTAGE 
Endometrial curettage frequently is performed in 
cases of possible ectopic pregnancy where the HCG is 
falling, but the location of the pregnancy is still 
uncertain. Ectopic pregnancy usually is ruled out if 
products of conception are found, except in rare cases 
of concomitant ectopic and intrauterine pregnancy. If 
no villi are found, laparoscopy is usually indicated to 
rule out ectopic pregnancy, unless the clinical picture 
strongly suggests a completed abortion. 
LAPAROSCOPY 
Laparoscopy is considered the optimal invasive 
diagnostic technique for identifying ectopic pregnancy. 
It is indicated in the patients with the following 
situations: 
0 a positive culdocentesis; 
0 transvaginal ultrasound showing no intrauterine sac 
with a complex adnexal mass and cul-de-sac fluid; 
transvaginal ultrasound showing no sac and HCG 
level is >2,000 mIU/mL; and 
falling HCG levels and endometrial curettage de- 
monstrating no villi (Nager & Murphy, 1991). 
Laparoscopy provides a positive diagnosis in >90% 
of cases of ectopic pregnancy. Missed diagnosis is 
usually limited to very early ectopic pregnancy (Stabile 
& Grudzinkas, 1990). Very unstable patients usually will 
need a laparotomy. 
DETECTION OF ECTOPIC PREGNANCY 
BY ALGORITHM 
Research shows that the clinical presentations and 
examination findings in patients with suspected ectopic 
pregnancy are extremely variable. From a review of the 
literature the diagnostic tests most helpful in 
identifying these patients are serial HCG levels, 
transvaginal ultrasound, and, if needed, endometrial 
curettage and laparoscopy. Nager and Murphy (1991) 
and Stovall and Ling (1991) have developed algorithms 
for the detection and management of ectopic 
pregnancy that are very useful in identifying when to 
perform these tests. Presented in Figure 1 is an 
algorithm for the detection and treatment of ectopic 
pregnancy adapted from these authors. The algorithm 
minimizes diagnostic errors and facilitates the initiation 
of appropriate treatment. 
TREATMENT STRATEGIES 
The management of ectopic pregnancy can be di- 
vided into two categories: surgical treatment and medi- 
cal management. Surgical treatment is further divided 
into conservative laparoscopic salpingostomy or salpin- 
gectomy and the more invasive laparotomy. Medical 
management includes chemotherapy with methotrex- 
ate or expectant management until spontaneous reso- 
lution occurs. These methods and the follow-up care 
for patients with ectopic pregnancy are reviewed in the 
following paragraphs. 
SURGICAL TREATMENT 
Few patients who are hemodynamically stable will 
require the increased cost and higher morbidity of 
laparotomy. In a study by Silva (1988) all 22 patients 
who presented with a hemodynamically stable ectopic 
pregnancy were treated by laparoscope. Stabile and 
Grudzinkas (1990) reviewed a study of 79 patients with 
ectopic pregnancy in which all were treated with 
laparoscopy and only 2 required further laparotomy to 
control for continued bleeding. Laparoscopy was 
associated with shorter hospital stay, less postoperation 
discomfort, and earlier return to normal activities. 
Currently, laparotomy is reserved for hemodynamically 
unstable patients only. 
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FIGURE 1. Algorithm for the detection and treatment of ectopic pregnancy. Adapted from Stovall and Ling (1991) and Nager and Murphy 
(1991). 
Intrauterine pregnancy rates and ectopic pregnancy 
recurrence rates were reviewed by Bateman and Taylor 
(1 99 1). After conservative laparoscopic surgery for 
ectopic pregnancy 49% to 64% of women were found to 
have subsequent intrauterine pregnancies and 12% to 
22% had recurrent ectopics. l%is study indicates that 
surgical treatment is effective in resolving ectopic preg- 
nancy but is associated with compromised future fertil- 
ity. New treatment options for ectopic pregnancy have 
been investigated in hopes of improving fertility out- 
comes. 
MEDICAL MANAGEMENT WITH 
OR WITHOUT METHOTREXATE 
Improved diagnostic techniques with earlier 
identification of ectopic pregnancy have made medical 
management of ectopic pregnancy a possibility. 
Methotrexate, a folic acid antagonist ideally suited for 
inhibition of rapidly growing cells such as mphoblasts, 
is the agent most extensively used in medical treatment. 
Kooi & Kock (1988) successfully treated 24 of 25 
patients with methotrexate injection into the area of 
tubal swelling. Several studies of methotrexate 
treatment were reviewed by Ory (1991). In one study, 
25 of 26 patients with ectopic pregnancy experienced 
resolution of the ectopic with methotrexate. Only one 
patient required a laparotomy for bleeding. 
Hysterosalpingograms were performed on 20 patients 
after 3 months and 15 had patent fallopian tubes. In 
another study, 34 of 36 women treated with 
methotrexate experienced successful resolution. It was 
suggested by Ory that methotrexate can be used in 
patients with ectopic pregnancy if the following exist: 
0 the patient is hemodynamically stable; 
0 no evidence of tubal rupture or hemorrhage is 
present; 
0 the tubal distention is <3 to 4 cm; 
0 no cardiac activity is seen in the ectopic gestation; 
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and 
0 the HCG level is <15,000 mILJ/mL. 
A variety of regimens have been used with mild and 
transient side effects when low doses are used. Prelimi- 
nary studies suggest a slightly better fertility potential in 
patients treated with methotrexate than with laparo- 
scopic salpingectomy or salpingostomy, but more re- 
search is needed. 
It remains unclear why some ectopic pregnancies 
continue to proliferate, invade tubal epithelium, and 
progress to rupture whereas others remain confined to 
the tube and are spontaneously reabsorbed. Stovall and 
Ling (1991) reviewed the research and documented 
cases of spontaneous resolution and found that a 
downward trend in HCG levels is characteristic of small 
unruptured ectopics destined to resolve. A rise in HCG 
levels indicates that surgical therapy or methotrexate 
should be instituted. 
In patients who require laparoscopy for confirmation 
of diagnosis there is no advantage to waiting for 
resolution. Because the patient already has experi- 
enced a surgical procedure, methotrexate or salpingec- 
tomy should be used to resolve the ectopic. Stable 
patients who have a confirmed nonlaparoscopic diag- 
nosis of ectopic pregnancy, with falling HCG levels and 
a gestation of <3.5 cm, and who do not wish surgery, 
can be observed for spontaneous resolution. Although 
the numbers are small and procedures still experimen- 
tal, expectant management with or without methotrex- 
ate may prevent the tubal damage caused by surgical 
treatment that results in compromised fertility. 
FOLLOW-UP CARE 
Ectopic pregnancy is often a rapidly unfolding 
condition in which there is insufficient time for the 
patient and family to begin adjustment to the loss until 
after the treatment has taken place. Many patients are 
unfamiliar with the term ectopic or tubal pregnancy 
and are unaware that it carries with it a 100% incidence 
of perinatal loss. The psychological needs of the woman 
and her family are the same as those of any person 
experiencing a pregnancy loss (Osguthorpe, 1987). 
Explanation of the grieving process can help the 
patient and family understand some of the reactions 
they are experiencing. Somatic responses such as loss of 
appetite, malaise, and sleeplessness are normal. Feel- 
ings of guilt and blame are often present. The patient 
and her family need factual information on causes of 
ectopic pregnancy and help to work through the guilt 
feelings. It is helpful to explain that each person reacts 
to and expresses loss differently. Open-ended questions 
may prompt the patient and family to share feelings and 
discuss concerns (Bowers, 1985). Assessment of when 
professional help is needed in grief work is part of the 
NP’s role. The patient and family should be encour- 
aged to participate in support groups for persons 
experiencing a pregnancy loss. Factual information on 
recurrence rates and the implications for future fertility 
should be given. Assisted reproductive techniques are 
options for patients with blocked or damaged tubes; 
however, these choices may have serious emotional, 
physical, and economic implications (Catlin & Wetzel, 
1991). Patients who have experienced one ectopic 
pregnancy are at significant risk for recurrence and 
should be instructed to obtain evaluation with HCG 
levels and ultrasound with subsequent pregnancies. 
Rh factor should be checked and Rho (D) immune 
globulin (RhoGAM) given to Rh negative women. 
Finally, patients who have been treated with methotrex- 
ate should use contraception for 3 months after treat- 
ment. Depending on the health of the patient, amount 
of blood loss, and type of treatment, contraception may 
be advised for one to three cycles after ectopic preg- 
nancy. A serum HCG level should be drawn to evaluate 
the patient for complete resolution of the ectopic. 
PROTOCOL DEVELOPMENT 
Review of the current literature on risk factors, 
diagnostic techniques, and treatment strategies has 
been incorporated into a protocol for use by NPs. A 
subjective data, objective data, assessment, and plan 
format (SOAP) similar to that used by Star, Shannon, 
Sammons, h m m e l ,  and Gutierrez (1990) has been 
used to facilitate prompt diagnosis, expedite treatment 
strategies, and improve follow-up care of the patient 
with ectopic pregnancy (Table 3).  
SUMMARY 
The number of ectopic pregnancies continues to 
increase in the United States. Recurrence rates after 
ectopic pregnancy are between 12% and 22% and 
subsequent infertility has been estimated at 36% to 
51%. There is a need to identify women at risk for 
ectopic pregnancy so that early detection can prevent 
tubal damage, life-threatening rupture, and the serious 
consequences of repeat ectopic pregnancy and infertil- 
ity. Risk factors identified in this article associated with 
ectopic pregnancy are: 
patient with a history of prior PID, prior ectopic 
pregnancy, tubal surgery, ovulation induction, assisted 
reproduction, using progesterone-only contraception, 
diethylstilbestrol exposure in utero, and recurrent spon- 
taneous abortion; 
patient with an unintended pregnancy while using an 
intrauterine device or following tubal ligation; 
0 older patient; and 
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TABLE 3. 
A PROTOCOL FOR ECTOPIC PREGNANCY 
1. Subjective Findings 
A. Risk factors 
1 .  History of: 
a. PID 
b. Prior ectopic pregnancy 
c. Tuba1 surgery 
d. Ovulation induction 
e. Assisted reproduction 
f. Use of progesterone-only pills 
g .  DES exposure in utero 
h. Recurrent spontaneous abortions 
2. Pregnant with an IUD 
3. Pregnant with a tuba1 ligation 
4. Women of older age 
5. Women of black or other minority race 
(Although many risk factors are associated with ectopic pregnancy, none make the diagnosis. Forty-two percent of patients have no 
risk factors present. A high index of suspicion should be maintained with these patients.) 
B. Clinical history 
The classic triad of symptoms is abdominal pain, missed menses, and vaginal bleeding; however, the symptoms can be extremely 
variable from a shocky unstable patient to an asymptomatic one. A ruptured ectopic pregnancy is a life-threatening emergency 
requiring immediate detection and surgical treatment. Stable patients with unruptured ectopic pregnancies can be managed in 
consultation with a physician. Any of the following symptoms are possible and are presented in order of frequency of occurrence. 
1. Abdominal pain 
2. Missed menses 
3. Vaginal bleeding 
4. Nausea and vomiting 
5. Dizziness 
6. Faintness and syncope 
7 .  Breast tenderness 
8 .  Urinary tract symptoms 
9. Shoulder pain 
10. Diarrhea 
11. Passage of tissue 
(The abdominal pain has been described as cramping, dull, achy, or sharp; mild, moderate, or severe; unilateral or bilateral; and 
located in any area of the abdomen.) 
II. Objective Findings 
A. Blood pressure is variable and correlates with blood loss 
B. Pulse is variable and often correlates with blood loss 
C. Temperature is usually normal, aiding in the differential diagnosis of PID 
D. Abdominal tenderness to palpation is common 
E. Rebound tenderness is less common 
F Adnexal tenderness may be present 
G. Pain with movement of the cervix may be present 
H. Uterus may be normal or enlarged 
I. Blood may be present in vagina 
(Because of the extreme variability in subjective and objective findings, in stable patients where time permits, additional diagnostic tests 
will be required to make the diagnosis of ectopic pregnancy.) 
111. AssessmentlDifferential Diagnosis 
A. Ectopic pregnancy 
B. R/O PID 
C. R/O Spontaneous abortion 
D. R/O Ruptured corpus luteum cyst 
E. R/O Pelvic mass 
F. R/O Appendicitis 
G. R/O Ureteral calculi or colic 
H. R/O Endornetriosis 
I. R/O Gestational trophoblastic neoplasia 
J. R/O Intrauterine pregnancy with inaccurate dates 
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TABLE 3 (continued). 
A PROTOCOL FOR ECTOPIC PREGNANCY 
IV. Plan (Consultation with or referral to gynecologist) 
Utilize the algorithm for detection and treatment in Figure 1 
A. Detection methods 
1. Biochemical tests 
2. When screening patients in the office setting, a urine HCG test sensitive to 30 mlU/mL will detect 99% of ectopic pregnancies. A 
negative test virtually excludes the diagnosis of ectopic pregnancy. 
B. Other tests done in the office setting in stable patients are: 
1.  Quantitative serial (every 2 days) HCG levels. Levels will double every 1.98 days in normal intrauterine pregnancies. Ectopic 
2. Blood type and Rh factor 
3. Complete blood count with differential 
4. Urinalysis for microscopic evaluation and culture 
5 .  Cervical cultures for gonorrhea and chlamydia 
1.  Ultrasound 
Transvaginal ultrasound should be performed in all patients with suspected ectopic pregnancy. A gestational sac can be visualized 1 
week earlier than with abdominal ultrasound at HCG levels of >2,000 mlU/mL. It is also superior in identifying other signs of ectopic 
pregnancy such as: identification and size of adnexal mass, extrauterine gestations, and free fluid in the cul-de-sac. 
pregnancies demonstrate an increase of ~ 6 6 %  in 2 days. 
C. Other tests 
2. Culdocentesis 
May be performed in cases where ultrasound is not readily available and in unstable patients. A positive tap is 0.5 cc of nonclotted 
blood, a negative tap is 0.5 cc of serosanguinous fluid, and no fluid is nondiagnostic. False positive results are possible. A negative 
tap can also occur when an ectopic is actually present (10%-14%). 
3. Endometrial curettage 
Performed in cases where the HCG level is falling but location of pregnancy is still uncertain. If products of conception are found, 
ectopic is usually excluded except in rare cases of heterotopic pregnancy. 
4. Laparoscopy 
The optimal invasive detection method, it is indicated in the following situations: 
a. Unstable patients 
b. Patients with a positive culdocentesis 
c. Patients with no sac, a complex adnexal mass, or fluid in the cul-de-sac on ultrasound 
d. Patients with no sac, an initial HCG level of 2,000, now subnormally increasing 
e. Patients with no sac, an initial HCG level of 2,000 now decreasing but no villi on D & C 
D. Treatment strategies (Surgical and expectant medical management is provided by obstetrician/gynecologist) 
1 .  Surgical management consists of laparoscopic salpingectomy or salpingostomy or laparotomy depending on the condition of the 
patient 
2. Expectant medical management with or without methotrexate may be possible in hemodynamically stable patients, with no evidence 
of tubal rupture or hemorrhage, a tubal distention of <3 to 4 cm with no cardiac activity, and an HCG level of <15,000 mlU/mL. 
E. Follow-up care 
1. Grief and loss counseling and assessment if professional help is needed 
2. Facilitation of patient and family participation in support groups for persons experiencing a pregnancy loss 
3. Provide information on recurrence and fertility rates after ectopic pregnancy 
4. Educate the patient that at any time she suspects she is pregnant in the future she should obtain evaluation with HCG levels and 
5.  Rh negative women should receive RhoGAM 
6. Contraception may be advised for 1-3 cycles 
7. Obtain serum HCG to evaluate for complete resolution of the ectopic pregnancy 
transvaginal ultrasound to confirm the location of the pregnancy 
Note PID = pelvic inflammatory disease, DES = diethylstilbestrol, IUD = intrauterine device, HCG =human chorionic gonadotropin, 
D & C = dilation and curettage 
0 black or other minority women. 
The majority of the risk factors except for PID are not 
preventable. NPs need to screen for causes of PID and 
educate patients on prevention via the use of condoms. 
Clinicians should be cognizant of the current risk 
factors and have an increased index of suspicion for 
ectopic pregnancy in patients with these risk factors. 
Further research on risk factors is needed. 
Improvement has been made in detection of ectopic 
pregnancy in recent years, probably contributing to the 
decrease in mortality. The clinical history and examina- 
tion remain variable; the most common symptoms are 
abdominal pain, amenorrhea, and bleeding. Diagnostic 
tests are more helpful than clinical findings. Serial HCG 
levels, transvaginal ultrasound, and, if needed, laparo- 
scopy and endometrial curettage are the most useful 
diagnostic tests and appropriate if used according to 
the algorithm in Figure 1. 
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Early detection of ectopic pregnancy has changed 
the treatment in the last decade to include, in stable 
patients, conservative laparoscopic surgery or expectant 
medical management with or without methotrexate. 
With these newer methods, improved rates of fertility 
and fewer recurrent ectopic pregnancies should occur. 
Follow-up care includes directing the patient and family 
to expert counseling and providing information on 
recurrence and fertility issues. 
Increased knowledge of risk factors, early diagnosis, 
appropriate management, and comprehensive follow- 
up care of patients with ectopic pregnancy is needed to 
lessen the serious impact of this complication of preg- 
nancy. 
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